American Society of Hirudotherapy

The leech: a novel invertebrate model for studying muscle regeneration and diseases

Review published in Curr Pharm Des (2010)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewDrug DevelopmentSalivary PharmacologyGrimaldi A et al. · Current pharmaceutical design, 2010

Abstract

We focused our studies on the leech, Hirudo medicinalis. This invertebrate has a relative anatomical simplicity and is a reliable model for studying a variety of basic events, such as tissue repair, which has a striking similarity with vertebrate responses. Hirudo is also a good invertebrate model to test the actions of drugs and gene products, since the responses evoked by the different stimuli are clear and easily detectable due to their small size and anatomical simplicity. Here we review the use of this invertebrate model to investigate muscle regeneration and the role of hematopoietic stem cells in this process. Our recent data, summarized in this review, demonstrate that the injection of an appropriate combination of the matrigel biopolymer supplemented with Vascular Endothelial Growth factor (VEGF) in the leech Hirudo medicinalis is a remarkably effective tool for isolating a specific population of hematopoietic/endothelial precursor cells, which in turn can differentiate in muscle cells. Thus leeches can be considered as a new emerging model for studying endothelial and hematopoietic precursors cells involved in muscle post-natal growth and regeneration processes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tReview
Indexed MeSH termsAnimalsCell Culture TechniquesCell DifferentiationCytokinesHematopoietic Stem CellsHirudo medicinalisModels, AnimalMusclesMyoblasts, SkeletalRegenerationVascular Endothelial Growth Factor AWound Healing

Summary

Reviews Hirudo medicinalis as a model for muscle regeneration: matrigel plus VEGF injection isolates a population of hematopoietic/endothelial precursor cells that can differentiate into muscle cells, useful for studying postnatal regeneration.

Why This Matters for Hirudotherapy

This review examined the use of Hirudo medicinalis as an invertebrate model for studying muscle regeneration, tissue repair, and the role of hematopoietic stem cells, including data showing that VEGF-supplemented matrigel injection isolates hematopoietic/endothelial precursor cells capable of differentiating into muscle cells. It is tangentially relevant to ASH's domain in that it positions the medicinal leech as a research organism for studying biological processes—tissue repair, stem cell biology—that may indirectly inform understanding of wound healing and regeneration. However, this study uses the leech as an experimental model organism, not as a therapeutic agent or source of therapeutic secretome compounds; it does not address hirudotherapy, leech saliva, or leech-derived anticoagulants. Its relevance to ASH's core domain is therefore limited to the leech as a biological subject rather than as a therapeutic modality.

Citation

The leech: a novel invertebrate model for studying muscle regeneration and diseases.

Grimaldi A et al. · Current pharmaceutical design, 2010

DOI

Added to ASH library: May 26, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.